Diversity: a priority for our companies, communities, and clinical trials
We know that diversity in our companies and communities brings a wealth of varied experiences and points of view. Did you know that diversity is also essential in clinical trials? One goal of a clinical trial is to represent the whole population within a disease state. Effectiveness, side effects and even performance of a device […]
Podcast: Mike DiCesare the President of Zephyrx
The DZS Dispatch: June 2022
The DZS Podcast is LIVE! Check out our newest podcast episodes! Read the entire June Newsletter Other Articles ICH E6(R3) Revisions: Is Your Team Ready for the Coming Changes?
ICH E6(R3) Revisions: Is Your Team Ready for the Coming Changes?
ICH E6(R3) Revisions: Is Your Team Ready for the Coming Changes? With potential changes in the design and development process on the horizon, we discuss the upcoming ICH E6(R3) revisions and the impact on clinical research A Look Back at Revision Two In 2016, ICH E6(R2) was introduced, focusing on trial participant protections and […]
Podcast: John Moore The Chairman of Scientific Industries (OTC – SCND)
Podcast: Guest: Terry Loding the Chief Operating Officer of X-Chem
The DZS Dispatch: April 2022
Staying Vigilant with Pharmacovigilance -Click image to read full newsletter-
Staying Vigilant with Pharmacovigilance
What is Pharmacovigilance? Medicinal products have transformed how we treat and prevent diseases, but they may also have unexpected side effects. As defined by the World Health Organization, Pharmacovigilance is the science and activity relating to the detection, assessment, and prevention of adverse effects or any other drug-related problem. It is a key way to […]
Site Monitoring in the Time of COVID
Remote monitoring in the spotlight By Maria Paluselli, MS, Project Manager and Medical Writer, DZS Clinical Services The COVID-19 pandemic has impacted nearly every facet of daily life, including conducting clinical research trials. Quarantines, site closures, travel limitations, supply chain for investigational product and necessary equipment, and the possibility of staff or study patients becoming […]